广发创新药ETF(515120)申购赎回 |
|
报告期 |
期初总份额(份) |
期末总份额(份) |
期间总申购份额(份) |
期间总赎回份额(份) |
期间净申赎份额(份) |
净申赎比例 |
2024/3/31 |
6,657,990,000 |
6,123,990,000 |
790,000,000 |
1,324,000,000 |
-534,000,000 |
-8.02% |
2023/12/31 |
2,420,990,000 |
6,657,990,000 |
7,026,000,000 |
2,789,000,000 |
4,237,000,000 |
175.01% |
2023/12/31 |
5,984,990,000 |
6,657,990,000 |
1,777,000,000 |
1,104,000,000 |
673,000,000 |
11.24% |
2023/9/30 |
5,256,990,000 |
5,984,990,000 |
1,512,000,000 |
784,000,000 |
728,000,000 |
13.85% |
2023/6/30 |
2,420,990,000 |
5,256,990,000 |
3,737,000,000 |
901,000,000 |
2,836,000,000 |
117.14% |
2023/6/30 |
3,273,990,000 |
5,256,990,000 |
2,601,000,000 |
618,000,000 |
1,983,000,000 |
60.57% |
2023/3/31 |
2,420,990,000 |
3,273,990,000 |
1,136,000,000 |
283,000,000 |
853,000,000 |
35.23% |
2022/12/31 |
1,617,990,000 |
2,420,990,000 |
2,609,000,000 |
1,806,000,000 |
803,000,000 |
49.63% |
2022/12/31 |
2,642,990,000 |
2,420,990,000 |
609,000,000 |
831,000,000 |
-222,000,000 |
-8.4% |
2022/9/30 |
1,809,990,000 |
2,642,990,000 |
1,086,000,000 |
253,000,000 |
833,000,000 |
46.02% |
2022/6/30 |
1,617,990,000 |
1,809,990,000 |
914,000,000 |
722,000,000 |
192,000,000 |
11.87% |
2022/6/30 |
1,730,990,000 |
1,809,990,000 |
345,000,000 |
266,000,000 |
79,000,000 |
4.56% |
2022/3/31 |
1,617,990,000 |
1,730,990,000 |
569,000,000 |
456,000,000 |
113,000,000 |
6.98% |
2021/12/31 |
1,621,990,000 |
1,617,990,000 |
2,886,000,000 |
2,890,000,000 |
-4,000,000 |
-0.25% |
2021/12/31 |
1,176,990,000 |
1,617,990,000 |
772,000,000 |
331,000,000 |
441,000,000 |
37.47% |
2021/9/30 |
717,994,000 |
1,176,990,000 |
930,000,000 |
471,000,000 |
459,000,000 |
63.93% |
2021/6/30 |
1,621,990,000 |
717,994,000 |
1,184,000,000 |
2,088,000,000 |
-904,000,000 |
-55.73% |
2021/6/30 |
1,271,990,000 |
717,994,000 |
137,000,000 |
691,000,000 |
-554,000,000 |
-43.55% |
2021/3/31 |
1,621,990,000 |
1,271,990,000 |
1,047,000,000 |
1,397,000,000 |
-350,000,000 |
-21.58% |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。